Assays of TSH-Receptor Antibodies in 576 Patients with Various Thyroid Disorders: Their Incidence, Significance and Clinical Usefulness

References

• Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endoer Rev 1984; 5: 309–355
   PubMed Web of Science ®Google Scholar
• Volpe R. Autoimmune thyroid disease. Autoimmunity in Endocrine Disease, R Volpé. Dekker, New York 1985; 109–285
   Google Scholar
• Zakarija M, McKenzie JM, Banovac K. Clinical significance of assay of the thyroid-stimulating antibody in Graves' disease. Ann Intern Med 1980; 93: 28–32
   PubMed Web of Science ®Google Scholar
• Zakarija M, Garcia A, McKenzie JM. Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease. J Clin Invest 1985; 76: 1885–1891
   PubMedGoogle Scholar
• Macchia E, Fenzi GF, Monzani F, Lippi F, Vitti P, Grasso L, Bartalena L, Baschieri L, Pinchera A. Comparison between thyroid-stimulating and TSH-binding inhibiting immunoglobulins of Graves: disease. Clin Endocrinol (Oxf) 1981; 15: 175–182
   Google Scholar
• Kohn LD, Rotella CM, Marcocci C, Toccafondi R, Pinchera A, Tombaccini D, Valente WA, De Luca M, Grollman EF. Monoclonal antibodies and autoimmune thyroid disease. Monoclonal Antibodies'84: Biological and Clinical Applications. Editrice Kurtis, Milano 1984; 169–199
   Google Scholar
• Kuzuya N, Chin SC, Ikeda H, Uchimura H, Ho K, Nagataki S. Correlation between thyroid stimulators and 3,5,3'-triidothyronine suppressibility in patients during treatment with thionamide drugs: comparison of assay by thyroid stimulating and thyroid displacing activities. J Clin Endocrinol Metab 1979; 48: 706–711
   Google Scholar
• Sugenoya A, Kidd A, Row VV, Volpé R. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves disease and other thyroid disorders. J Clin Endocrinol Metab 1979; 48: 398–402
   Google Scholar
• Endo K, Kasagi K, Konishi J, Ikekubo T, Okuno T, Takeda Y, Mori T, Torikuza K. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 1978; 46: 734–738
   PubMed Web of Science ®Google Scholar
• O'Donnell J, Trokoudes K, Silverburg J, Row VV, Volpé R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab 1978; 46: 770–777
   PubMedGoogle Scholar
• Ozawa Y, Maciel RMB, Chopra IJ, Solomon DH, Beall GN. Relationship among immunoglobulin markers in Graves' disease. J Clin Endocrinol Metab 1979; 48: 381–387
   Google Scholar
• Muktar ED, Smith BR, Vice P, Hall R, Pyle GA. Relation of thyroid-stimulating immunoglobulins to thyroid function and effect of surgery, radioiodine and antithyroid drugs. Lancet 1975; 1: 713–715
   Google Scholar
• McGregor AM, Smith BR, Hall R, Petersen MM, Miller M, Dewer PJ. Prediction of relapse in hyperthyroid Graves' disease. Lancet 1980; 1: 1101–1109
   PubMed Web of Science ®Google Scholar
• Schleusener H, Kotulla P, Finke R, Sorje H, Meinhold H, Adlkofer F, Wenzel KW. Relationship between thyroid status and Graves' disease-specific immunoglobulins. J Clin Endocrinol Metab 1978; 47: 379–384
   PubMed Web of Science ®Google Scholar
• Madec AM, Laurent MC, Lorcy Y, Le Guerrier AM, Rostagnat-Stefanutti A, Orgiazzi J, Allannic H. Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease. Clin Endocrinol (Oxf) 1984; 21: 247–255
   Google Scholar
• Hensen J, Kotulla P, Finke R, Badenhoop H, Koppenhagen K, Meinhold H, Scleusener H. 10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb). J Endocrinol Invest 1984; 7: 215–220
   Google Scholar
• Teng CS, Yeung TT. Changes in thyroid stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. J Clin Endocrinol Metab 1980; 50: 144–147
   PubMed Web of Science ®Google Scholar
• Davies TF, Evered DC, Smith BR, Yeo PPB, Clark F, Hall R. Value of thyroid-stimulating antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Lancet 1977; 1: 1181–1182
   Google Scholar
• Bech K, Madsen SN. Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. Clin Endocrinol (Oxf) 1980; 13: 417–424
   Google Scholar
• Davies TF, Platzer M, Farid NR. Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status. Clin endocrinol. (Oxf.) 1982; 16: 183–191
   Google Scholar
• Orgiazzi J, Madec AM, Genetet N, Gueguen M, Allannic H. Immunological parameters in Graves' disease: are they useful for indication and monitoring of antithyroid drug treatment?. Horm Res 1987; 26: 131–136
   Google Scholar
• Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen H, Wenzel W. HLA-DR3 and HLA-DR5 associated thyrotoxicosis-two different types of toxic diffuse goitre. J Clin Endocrinol Metab 1983; 56: 781–785
   PubMedGoogle Scholar
• Bliddal H, Bech K, Feldt-Rasmussen U, Thomsen M, Ryder LP, Hansen JM, Siersbaek-Nielsen K, Friis T. Thyroid-stimulating immunoglobulins in Hashimoto's thyroiditis measured by radioreceptor assay and adenylate cyclase stimulation and their relationship to HLA-D allels. J Clin Endocrinol Metab 1982; 55: 995–998
   Google Scholar
• Kidd A, Okita N, Row VV, Volpe R. Immunological aspects of Graves' and Hashimoto's diseases. Metabolism 1980; 29: 80–99
   PubMed Web of Science ®Google Scholar
• Smyth PPA, Neylan D, O'Donovan DK. The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay. J Clin Endocrinol Metab 1982; 54: 357–361
   PubMedGoogle Scholar
• Grubeck-Loebenstein B, Dergler K, Kassal H, Knapp W, Krisch K, Liszka K, Smyth PPA, Waldhausl W. Immunological features of nonimmunogenic hyperthyroidism. J Clin Endocrinol Metab 1985; 60: 150–155
   PubMed Web of Science ®Google Scholar
• Smith BR. Immunology of the thyrotropin receptor. Immunol Commun 1976; 5: 345–360
   PubMed Web of Science ®Google Scholar
• Schatz H. Klinische Wertigkeit von Schilddrüsenantikörper-Testen. Schilddrüse 1983, CR Pickardt, H Schleusener, B Weinheimer. Georg Thieme Verlag, Stuttgart 1985; 76–94
   Google Scholar
• Konishi J, Lida Y, Kasagi K, Misaki T, Nakashima Endo K, Mori T, Shinpo S, Nohara Y, Matsuura N, Torizuka K. Primary myxedema with thyrotropin-binding inhibitor immunoglobulins. Ann Intern Med 1985; 103: 26–31
   PubMedGoogle Scholar
• Arikawa K, Ichikawa Y, Yoshida T, Shinozawa T, Homma M, Momotani N, Ito K. Blocking type antithyrotropin receptor antibody in patients with non-goitrous hypothyroidism: its incidence and characteristics of action. J Clin Endocrinol Metab 1985; 60: 953–959
   PubMedGoogle Scholar
• Takasu N, Mori T, Koizumi Y, Takeuchi S, Yamada T. Transient neonatal hypothyroidism due to maternal immunoglobulins that inhibit thyrotropin-binding and post-receptor processes. J Clin Endocrinol Metab 1984; 59: 142–146
   PubMed Web of Science ®Google Scholar
• Strakosch CR, Joyner D, Wall JR. Thyroid stimulating antibodies in patients with subacute thyroiditis. J Clin Endocrinol Metab 1978; 46: 345–348
   PubMedGoogle Scholar
• Wall JR, Strakosch CR, Bandy P, Bayly R. Nature of thyrotropin displacement activity in subacute thyroiditis. J Clin Endocrinol Metab 1982; 54: 349–353
   PubMedGoogle Scholar
• Kraiem Z, Glaser B, Ygla M, Pauker J, Sadeh O, Shienfeld M. Toxic multinodular goitre: a variant of autoimmune hyperthyroidism. J Clin Endocrinol Metab 1987; 65: 659–664
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosenbrough NJ, Farr AL, Randall NJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Carayon P, Macchia E, Fenzi GF, Pinchera A, Lissitzky S. Agonism and antagonism of immunoglobulins from Graves' disease patients on TSH-stimulated thyroid adenylate cyclase. Autoimmune Aspects of Endocrine Disorders, A Pinchera, D Doniach, GF Fenzi, L Baschieri. Academic Press, London 1979; 167–173
   Google Scholar
• Baldet L, Madec AM, Papachristou C, Stefanutti A, Orgiazzi J, Jafflol C. Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?. Acta Endocrinol 1987; 116: 7–12
   Google Scholar
• Weetman AP, Ratanachaiyavong S, Middleton GW, Love W, John R, Owen GM, Darke C, Lazarus JH, Hall R, McGregor AM. Prediction of outcome in Graves' disease after carbimazole treatment. Quart J Med 1986; 59: 409–419
   PubMedGoogle Scholar
• Bolk JH, Elta JWF, Bussemaker JK, Haak A, Van der Heide D. Thyroid-stimulating immunoglobulins do not cause non-autonomous, autonomous, or toxic multinodular goitres. Lancet 1979; 2: 61–63
   Google Scholar